Skip to main content

and
  1. No Access

    Article

    Significant association of anti-platelet factor 4/heparin antibody with cardiovascular disease in hemodialysis patients: a longitudinal 7-year study

    Hemodialysis patients have a high incidence of anti-platelet factor 4/heparin antibody (PF4-H Ab) and are at a high risk of cardiovascular disease. This study determines the association between PF4-H Ab and ca...

    Chi-Chu Liu, Li-** Chou, Tsang-Shan Chen in International Urology and Nephrology (2018)

  2. No Access

    Article

    Low serum phosphate is associated with ischemic stroke in hemodialysis patients

    Hemodialysis patients have a high incidence of ischemic stroke. However, the association between serum phosphate levels and ischemic stroke is controversial among hemodialysis patients. The present study is us...

    Tsang-Shan Chen, Chao-Hung Chen, Chien-An Chen in Clinical and Experimental Nephrology (2018)

  3. No Access

    Article

    Serum ferritin is associated with arterial stiffness in hemodialysis patients: results of a 3-year follow-up study

    Iron may contribute to vascular injury through reactive oxygen species. Hemodialysis patients frequently receive iron supply for correction of anemia and are at a high risk of cardiovascular disease. We tested...

    Kao-Chang Lin, Meng-Yi Tsai, Chun-Ling Chi in International Urology and Nephrology (2015)

  4. No Access

    Article

    Serum ferritin is associated with progression of peripheral arterial disease in hemodialysis patients

    Dialysis patients received intravenous iron to treat anemia and had high prevalence of peripheral artery disease (PAD). We hypothesized that high iron status might associate with the progression of PAD among h...

    Chen-Tung Lien, Kao-Chang Lin, Yueh-Feng Tsai in Clinical and Experimental Nephrology (2015)

  5. No Access

    Article

    Anti-platelet factor 4/heparin antibody is associated with progression of peripheral arterial disease in hemodialysis patients

    Heparin therapy may induce anti-platelet factor 4/heparin antibody (PF4-H Ab). Hemodialysis patients receive scheduled heparin and are at a risk of develo** PF4-H Ab. Hemodialysis patients are also at a high...

    Yen-Hsun Chen, Kao-Chang Lin, Yueh-Feng Tsai in International Urology and Nephrology (2015)

  6. No Access

    Article

    Anti-PF4/heparin antibodies are associated with arteriovenous fistula thrombosis in non-diabetic hemodialysis patients

    Anti-platelet factor 4/heparin complex antibodies (anti-PF4/heparin Ab) have been found to cause heparin-induced thrombocytopenia (HIT), a clinical syndrome thrombocytopenia and thrombosis. There is still cont...

    Yueh-Feng Tsai, Chien-An Chen, Chieh Kuo in Clinical and Experimental Nephrology (2012)